Skip to main content
. 2020 Sep 16;12(9):2639. doi: 10.3390/cancers12092639
AR Androgen receptor
AR-V7 Androgen receptor splice variant 7
CK20 Cytokeratin 20
DSS Disease-specific survival
GP88 Progranulin
GS Gleason score
HR Hazard ratio
IHC Immunohistochemistry
IRS Immunoreactive score
OS Overall survival
PCa Prostate carcinoma
Pn Perineural invasion
RFS Relapse-free survival
TMA Tissue micro array